Shigella mediated regulation of epithelial cell inflammasomes
志贺氏菌介导的上皮细胞炎症小体的调节
基本信息
- 批准号:10608342
- 负责人:
- 金额:$ 76.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-14 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:ActinsAcuteAntibiotic ResistanceBacteriaBindingBinding ProteinsCASP1 geneCASP4 geneCASP5 geneCaspaseCell DeathCell membraneCell physiologyCellsCessation of lifeCollaborationsColonComplexCytolysisCytosolDataDevelopmentDiarrheaEnvironmentEpithelial CellsEpitheliumFaceFutureGBP1 geneGastrointestinal tract structureGoalsGrowthHost DefenseHumanIL18 geneImmune responseInfectionInfection preventionInflammasomeInflammationInflammatoryInnate Immune ResponseInterferonsInterleukin-1 betaInterruptionInterventionInvadedIonsKnowledgeLearningLipid ALipopolysaccharidesMediatingModelingModificationMusN-terminalNeutrophil InfiltrationOralOrthologous GeneOspC proteinPathogenesisPeptide HydrolasesPersonsPreventionProcessProteinsRegulationResearchRoleShigellaShigella InfectionsSpecificitySwellingTestingTissuesType III Secretion System PathwayUbiquitinVariantWorkcell motilitycytokinedesignenteric infectionenteric pathogengain of functionguanylategut inflammationhuman pathogenimprovedinnovationinterestintestinal epitheliumneutrophilnovelpathogenpathogenic bacteriarecruitsensor
项目摘要
Shigella species are important, highly infectious pathogens of humans. In 2016, there were ~269 million cases
and 212,000 deaths due to Shigella. Infection with Shigella is associated with inflammation due to the recruitment
of neutrophils to the colon and massive tissue destruction. Despite this impressive host response, Shigella
survive in this harsh environment, primarily by replicating within and spreading between colonic epithelial cells
(ECs). Shigella survive by directly usurping and reprogramming host cell processes through the activity of ~30
type III effectors, proteins that they directly inject into the host cell cytosol via a highly conserved type III secretion
system (T3SS). Our research's overall goal is to use Shigella as a model pathogen to decipher the mechanisms
that enable intracellular pathogens to evade host innate immune responses and establish a replicative niche with
the cytosol of intestinal ECs. We have a long-standing interest in identifying and deciphering roles for effectors
in specific steps in Shigella pathogenesis. The first line of defense that Shigella and other enteric pathogens face
upon trying to establish a replicative niche within the gastrointestinal tract is the induction of the death of intestinal
ECs via pyroptosis. Pyroptosis is an inflammatory form of cell death that, if not inhibited, results in the rapid lysis
and/or expulsion of infected ECs from the intestinal epithelium and the processing and release of pro-
inflammatory cytokines. Here, we propose to investigate how Shigella type III secreted effectors cooperate to
inhibit pyroptosis, thus enabling this professional intracytoplasmic pathogen to establish a replicative niche within
the cytosol of intestinal epithelial cells. These studies are designed to significantly expand our understanding of
how Shigella, and likely other enteric pathogens, inhibit inflammasomes. At the completion of the proposed aims,
it is expected that the knowledge gained can be applied towards the development of novel host-based
interventions for the prevention and treatment of enteric infections, a particularly pressing need given emerging
issues with antibiotic resistance.
志贺氏菌是人类的重要,高度感染性的病原体。在2016年,有约2.69亿个案件
志贺氏菌造成的212,000人死亡。志贺氏菌感染与由于招募而引起的炎症
嗜中性粒细胞到结肠和巨大的组织破坏。尽管有这种令人印象深刻的主人反应,Shigella
在这种严酷的环境中生存,主要是通过在结肠上皮细胞之间复制和扩散
(EC)。志贺氏菌通过直接篡改和重新编程的宿主细胞过程来生存
III型效应子,通过高度保守的III型分泌直接注入宿主细胞胞质的蛋白质
系统(T3SS)。我们的研究的总体目标是使用志贺氏菌作为模型病原体来破译机制
这使细胞内病原体能够逃避宿主的先天免疫反应,并建立一个复制的生态位
肠道EC的细胞质。我们对识别和破译效应子的角色一直很感兴趣
在志贺氏菌发病机理的特定步骤中。 Shigella和其他肠道病原体面对的第一道防线
试图在胃肠道内建立复制生态位,是肠道死亡的诱导
EC通过凋亡。凋亡是一种细胞死亡的炎症形式,如果不抑制,会导致快速裂解
和/或从肠上皮中驱逐感染EC以及促进和释放
炎症细胞因子。在这里,我们建议调查志贺氏奇型III型分泌效应子如何合作
抑制凋亡,从而使这种专业的胞质内病原体能够在
肠上皮细胞的细胞质。这些研究旨在显着扩大我们对
志贺氏菌以及可能的其他肠道病原体如何抑制炎症。拟议的目标完成时,
预计所获得的知识可以应用于开发基于新型宿主的新知识
预防和治疗肠道感染的干预措施,出现了特别紧迫的需求
抗生素抗性的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAMMIE LESSER其他文献
CAMMIE LESSER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAMMIE LESSER', 18)}}的其他基金
Designer EcN for treatment of solid tumors
用于治疗实体瘤的 Designer EcN
- 批准号:
10459848 - 财政年份:2022
- 资助金额:
$ 76.16万 - 项目类别:
Designer EcN for treatment of solid tumors
用于治疗实体瘤的 Designer EcN
- 批准号:
10565935 - 财政年份:2022
- 资助金额:
$ 76.16万 - 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
- 批准号:
10328544 - 财政年份:2019
- 资助金额:
$ 76.16万 - 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
- 批准号:
10274790 - 财政年份:2019
- 资助金额:
$ 76.16万 - 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
- 批准号:
10411510 - 财政年份:2019
- 资助金额:
$ 76.16万 - 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
- 批准号:
10553659 - 财政年份:2019
- 资助金额:
$ 76.16万 - 项目类别:
Dissecting the means by which type 3 substrates are defined & secreted
剖析 3 类底物的定义方式
- 批准号:
10589974 - 财政年份:2019
- 资助金额:
$ 76.16万 - 项目类别:
PIPs: a new means to identify effector-target interactions
PIP:识别效应器-目标相互作用的新方法
- 批准号:
8777643 - 财政年份:2014
- 资助金额:
$ 76.16万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure
Lcn10 在脓毒症引起的血管渗漏和心力衰竭中的作用
- 批准号:
10532242 - 财政年份:2021
- 资助金额:
$ 76.16万 - 项目类别:
Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure
Lcn10 在脓毒症引起的血管渗漏和心力衰竭中的作用
- 批准号:
10340332 - 财政年份:2021
- 资助金额:
$ 76.16万 - 项目类别:
Microbiome and E. coli O157:H7 infection of human gut tissue
人体肠道组织的微生物组和大肠杆菌 O157:H7 感染
- 批准号:
10208643 - 财政年份:2018
- 资助金额:
$ 76.16万 - 项目类别:
Microbiome and E. coli O157:H7 infection of human gut tissue
人体肠道组织的微生物组和大肠杆菌 O157:H7 感染
- 批准号:
9764263 - 财政年份:2018
- 资助金额:
$ 76.16万 - 项目类别: